MedTrace Logo

Analgesic Non Inferiority of the Thoracic Bi-block in Comparison With Thoracic Epidural for VATS.

NCT04538235 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2020-09-04

No results posted yet for this study

Summary

Video-Assisted thoracic surgery (VATS) is the standard treatment for localized lung cancer. However, there is no consensus on analgesic management in patients undergoing VATS.

The aim of the study is to compare the analgesic efficacy of thoracic epidural with that a "Bi-block" combining an Erector Spinae muscle plane Block (ESP) and a Serratus Anterior Block (SAP) in patients undergoing VATS for lung or pleural surgery.

Our main hypothesis is that the analgesic efficacy of the Bi-block, assessed by morphine consumption, is not inferior to that provided by a thoracic epidural during the first 48 hours after VATS. We conducted a age, gender and type of surgery-matched retrospective cohort study in the Department of Thoracic Anesthesia of the Montpellier University Hospital (France).

Conditions

  • Erector Spinae Muscle Plane Block
  • Serratus Anterior Muscle Plane Block
  • Video-Assisted Thoracic Surgery
  • Lung Cancer
  • Pleural Diseases
  • Thoracic Epidural
  • Analgesia
  • Enhanced Recovery After Surgery

Interventions

PROCEDURE

Thoracic Regional Analgesia

In the TEA group, a thoracic epidural was performed before VATS. In the Bi-block group, a SAP block associated with an ESP block were performed before surgical incision under general anesthesia.

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Pierre Sentenac, MD · Montpellier University Hospital

  • Pascal H Colson, MD, PhD · Montpellier University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-20
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04538235 on ClinicalTrials.gov